Decoding brain disease to reimagine drug developmenthttps://bsky.app/profile/quiverbioscience.bsky.socialhttps://bsky.app/profile/quiverbioscience.bsky.social/post/3mac5z6v5ts2uWe’re gearing up for #JPM26 in just a few weeks! We’ll be sharing updates on our internal therapeutics programs, exploring investment and out-licensing opportunities, and discussing how our unique platform can accelerate CNS drug discovery for our partners. #pain #neuroscience #drugdiscovery #AI18 Dec 2025 21:53 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3mac5z6v5ts2uhttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lv7djwit422o99°F in Cambridge? Perfect weather for the Quiver Bioscience summer picnic! ☀️🍔 We beat the heat together with burgers, BBQ, frozen treats, and great conversations!30 Jul 2025 19:17 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lv7djwit422ohttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lswgugqpvc2oQuiver Bioscience Secures Non-Dilutive Funding to Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities and Advance Powerful AI/ML-Based In Vitro / In Silico Predictor of CNS Drug Safety - https://www.businesswire.com/news/home/20250701969448/en/Quiver-Bioscience-Secures-Non-Dilutive-Funding-to-Enhance-CNS-Genetic-Medicine-Drug-Discovery-Platform-Capabilities-and-Advance-Powerful-AIML-Based-In-Vitro-In-Silico-Predictor-of-CNS-Drug-Safety?utm_campaign=shareaholic&utm_medium=bluesky&utm_source=socialnetwork01 Jul 2025 19:32 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lswgugqpvc2ohttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lrt6kea3mc2tQuiver has officially announced appointment of Graham T. Dempsey, co-founder and former CSO, as CEO. Dr. Dempsey has dedicated over a decade of leadership to Quiver, bringing deep technical and commercial expertise in neuroscience and drug discovery. https://www.businesswire.com/news/home/20250616969477/en/Quiver-Bioscience-Appoints-Graham-Dempsey-PhD-as-Chief-Executive-Officer-to-Lead-Scaling-of-AI-Driven-CNS-Platform-and-Advance-Lead-Program-into-the-Clinic17 Jun 2025 19:00 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lrt6kea3mc2thttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lpa4w5t3322z📣 News Alert! 📣 We are pleased to announce a research collaboration with QurAlis to advance an innovative approach to the treatment of Fragile X syndrome (FXS), the leading genetic form of intellectual disability and ASD. 📰 Read the full Press Release here: https://www.businesswire.com/news/home/20250513083387/en/Quiver-Bioscience-and-QurAlis-Announce-Research-Collaboration-to-Advance-Novel-Therapeutic-Approach-for-Fragile-X-Syndrome15 May 2025 18:20 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lpa4w5t3322zhttps://bsky.app/profile/quiverbioscience.bsky.social/post/3logl5uxqas2pWe are excited to welcome Dr. Shafali Jeste as a member of our Scientific Advisory Board! Dr. Jeste is Professor of Pediatrics and Neurology at the USC Keck School of Medicine, and the Las Madrinas Chair, Chief of Neurology and Co-Director of the Neurological Institute at CHLA. Welcome to our team!05 May 2025 14:26 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3logl5uxqas2phttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lkqoi2ltks2gQuiver Bioscience Announces Collaboration with the Dup15q Alliance to Advance Antisense Oligonucleotide Therapeutic Program - https://www.businesswire.com/news/home/20250319530660/en/Quiver-Bioscience-Announces-Collaboration-with-the-Dup15q-Alliance-to-Advance-Antisense-Oligonucleotide-Therapeutic-Program?utm_campaign=shareaholic&utm_medium=bluesky&utm_source=socialnetwork19 Mar 2025 17:11 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lkqoi2ltks2ghttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lgqjz3uia22b27 Jan 2025 18:10 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lgqjz3uia22bhttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lfnjuealek2t13 Jan 2025 20:04 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lfnjuealek2thttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lcl2yehomc2rWe are looking forward to participating at the American Epilepsy Society Annual Meeting #AES2024 in Los Angeles! Stop by our poster to learn more about how we are supporting drug development with collaborators at Biohaven!05 Dec 2024 16:17 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lcl2yehomc2rhttps://bsky.app/profile/quiverbioscience.bsky.social/post/3lbkhmt6qhf2f📣|News Alert: https://www.businesswire.com/news/home/20241121903871/en 📰Link to full text of publication here: https://www.nature.com/articles/s42003-024-07120-622 Nov 2024 17:05 +0000at://did:plc:xy542cgyi2nicdbc7dm4fpty/app.bsky.feed.post/3lbkhmt6qhf2f